Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

NCT01722305

Conditions
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Burkitt Lymphoma, Central Nervous System Lymphoma, +23 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas

NCT02401048

Conditions
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • Site-0397 Birmingham, Alabama, United States
  • Site-0047 Duarte, California, United States
  • Site-0038 Stanford, California, United States
  • Site-0388 Miami, Florida, United States
View Trial Details
Completed

To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL

NCT02624492

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Jessa Ziekenhuis - Campus Virga Jesse Hasselt, Belgium
  • Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
  • Istituto Clinico Humanitas Rozzano (MI), Italy
  • A. O. S. Maria della Misericordia Udine, Italy
View Trial Details

Related conditions